COVID-19 infection in 10 common variable immunodeficiency patients in New York CityBarrie Cohen, Rachel Eisenberg, Arye Rubinstein et al.|The Journal of Allergy and Clinical Immunology In Practice|2020Cited by 40
Long-term safety of facilitated subcutaneous immunoglobulin 10% treatment in patients with primary immunodeficiency diseases: final analysis from a post-authorization safety study conducted in the USAArye Rubinstein, Leman Yel, Mohsen Mabudian et al.|Clinical Immunology|2023Cited by 1